# A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

> clinical trial · VERIFIED · 2026-08-11

Status: RECRUITING · Sponsor: Bristol-Myers Squibb · Condition: Plaque Psoriasis

- Company: Bristol-Myers Squibb
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06979453

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.